analysis was based on 2010 WHO reference criteria. Serum hormones and sperm DNA fragmentation index (SDF) (SDF !30% as pathologic) were measured in every patient. Circulating triglyceride (TGL), total cholesterol (Chol), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) levels were measured. Each lipid parameter was categorized into quartiles. The association of the hormonal milieu and semen parameters with the lipid profile was analysed.
INTRODUCTION AND OBJECTIVES:
The prevalence of Klinefelter syndrome (KS) (ranging from 0.1 to 0.2% in newborn male infants) rises up to 3-4% among infertile males and 10-12% in azoospermic patients. The most common reproductive abnormality in KS is non-obstructive azoospermia (NOA), and approximately 11% of men with NOA will have KS. With recent advances in reproductive medicine, sperm can be retrieved via surgical testicular sperm extraction (TESE) in around 50% of men seeking biological fertility. This falls in KS according to most studies.
Hormone stimulation prior to a sperm retrieval procedure has been used in men with low testosterone levels and infertility. Clomiphene citrate is a selective oestrogen receptor modulator that blocks negative feedback at the level of the hypothalamus and pituitary thus increasing both LH and FSH secretion. HCG and recombinant FSH can also be used for testosterone stimulation is there is limited response to clomiphene citrate. The efficacy of testosterone stimulation and subsequent sperm retrieval in KS is not well documented.
METHODS: A prospective multi-centre database was created using every KS patient undergoing micro-TESE between 2014-2018. Demographic details, hormone levels, hormone stimulation treatment (delivered in a step-wise regime for 6 months), sperm retrieval rates, pregnancy rates and live birth rates were recorded.
RESULTS: During the period analysed we had 23 patients with KS who underwent micro-TESE. Median age (IQR) was 33 years old (30-34), median testosterone 8.1 nmol/L (5.3-12.9), median FSH 35.4 IU/L (23.6-38.9) and median LH 22.5 IU/L (16.1-26.8). From this group of patients, 15 had hormone stimulation for 6 months and 8 did not, prior to micro-TESE. In the hormone stimulation group sperm retrieval rates were 40% (6/15) compared to 13% (1/8) in the group without prior stimulation. In the hormone stimulation group pregnancy rates were 27% (4/15) and live birth rates were 20% (3/15).
CONCLUSIONS: The use of hormone stimulation in KS patients undergoing micro-TESE appears to improve their pre-surgery testosterone levels and provides a better success rate of sperm retrieval. This has been shown to then result in a high pregnancy and live birth rates compared to other studies.
Source of Funding: none

MP46-06 PERIPHERAL BLOOD CELL COUNTS OF AZOOSPERMIC MEN IN RELATION TO TESTICULAR HISTOPATHOLOGY
Shoichiro Iwatsuki*, Tomoki Takeda, Satoshi Nozaki, Takahiro Kobayashi, Yasue Kubota, Hiroki Kubota, Hiroyuki Kamiya, Yukihiro Umemoto, Takahiro Yasui, Nagoya, Japan INTRODUCTION AND OBJECTIVES: Evaluation of peripheral blood cell count is a non-invasive method used for the detection of systemic inflammation. Several researchers have proposed that inflammatory mechanisms may contribute to spermatogenic failure, suggesting that the peripheral blood cell count of men with azoospermia may change according to the severity of testicular degeneration. In this study, we evaluated the peripheral blood cell count of men with azoospermia in relation to testicular histopathology.
METHODS: A total of 68 patients with idiopathic obstructive or nonobstructive azoospermia who underwent surgical sperm extraction at Nagoya City West Medical Center, Nagoya, Japan were enrolled in this study. The patients were divided into four groups according to their testicular biopsy results: normospermatogenesis (NS, n [ 8), hypospermatogenesis (HS, n [ 19), maturation arrest (MA, n [ 19), and Sertoli cell-only syndrome (SCO, n [ 22). Total and differential white blood cell (WBC), red blood cell (RBC), hemoglobin (Hb), hematocrit (Hct), and platelet (Plt) measurements in each group were compared using the Jonckheere-Terpstra test.
RESULTS: There was no difference in the total and differential WBC and Plt count in each group. The median and range of the RBC count in the NS, HS, MA, and SCO groups were 515 (449 -538), 501 (439 -575), 497 (436 -545) , and 485 (441 -526) Â 10 4 mL, respectively, showing a significant tendency (p < 0.05) to decrease as testicular histopathology became more severe ( Figure A) . Showing a similar tendency, the median and range percent Hct in each group was 44.4 (41.4 -49.7), 44.0 (38.2 -46.7), 43.7 (40.2 -47.90), and 42.1 (39.1 -45.7), respectively ( Figure B) . There was no difference in the Hb count in each group.
CONCLUSIONS: This is the first report demonstrating a relationship between testicular histopathology and RBC count. Patients with more severely impaired spermatogenesis had more reduced peripheral RBC count. Taken together with the fact that Sertoli cells are a source of the serum iron transporter transferrin, our results indicate that the decrease in RBC count in the patients with more severe spermatogenic failure reflects Sertoli cell dysfunction.
